製药自动化市场规模、份额及成长分析（按产品、自动化模式、最终用户、应用和地区）－2025-2032 年产业预测

2023 年全球製药自动化市场规模为 75.6 亿美元，预计将从 2024 年的 83.8 亿美元成长到 2032 年的 190.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.8%。

由先进的分析和软体驱动的药房自动化设备正在改变全球零售药房的格局，显着提高盈利和效率。自动化的实施简化了药师的工作流程管理，并优先考虑患者满意度，同时显着减少药物浪费并降低每剂成本。随着处方药和非处方药价格上涨，製药公司正在转向自动化，以在不影响品质或安全的前提下提高产量。这项技术创新符合弹性自动化和数数位化等现有趋势，这些趋势在新冠疫情期间得到了支持，从而可以实现更快、更灵活的生产线。总体而言，自动化的推动力正在再形成产业，并使企业在艰难的市场环境中实现永续成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局

製药自动化市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 硬体
• 软体
• 服务

製药自动化市场规模（依自动化模式和复合年增长率） (2025-2032)

• 市场概览
• 全自动系统
• 半自动系统

製药自动化市场规模（依最终用户和复合年增长率）(2025-2032)

• 市场概览
• 製药公司
• 研究部门
• 契约製造组织（CMO）
• 合约研究组织（CRO）

製药自动化市场规模（按应用和复合年增长率）（2025-2032）

• 市场概览
• 药物研发
• 药物开发
• 临床试验
• 製造业
• 包装
• 品管

製药自动化市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Becton, Dickinson and Company（USA）
• Baxter International Inc.（USA）
• Siemens Healthineers（Germany）
• GE Healthcare（USA）
• Omnicell, Inc.（USA）
• Swisslog Healthcare（Switzerland）
• Capsa Healthcare（USA）
• Parata Systems（USA）
• ARxIUM（Canada）
• ScriptPro LLC（USA）
• Yuyama Co., Ltd.（Japan）
• McKesson Corporation（USA）
• Pearson Medical Technologies（USA）
• Accu-Chart Plus Healthcare Systems（USA）
• NewIcon（Finland）
• AlixaRx（USA）
• KUKA AG（Germany）
• TOSHO Inc.（Japan）
• Cerner Corporation（USA）

结论和建议

Global Pharmaceutical Automation Market size was valued at USD 7.56 billion in 2023 and is poised to grow from USD 8.38 billion in 2024 to USD 19.03 billion by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

Pharmacy automation devices, powered by advanced analytics and software, are transforming the global retail pharmacy landscape, enhancing profitability and efficiency significantly. The adoption of automation has drastically cut medication waste, lowering the cost per dose, while simplifying workflow management for pharmacists and prioritizing patient satisfaction. In light of skyrocketing prices for prescription and over-the-counter medications, pharmaceutical companies are leveraging automation to boost production without compromising quality or safety. This innovation enables faster and more flexible production line construction, aligning with existing trends like flexible automation and digitalization that gained traction during the COVID-19 pandemic. Overall, the push toward automation is reshaping the industry and positioning companies for sustainable growth amidst challenging market conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Automation Market Segments Analysis

Global Pharmaceutical Automation Market is segmented by Offering, Mode of Automation, End User, Application and region. Based on Offering, the market is segmented into Hardware, Software and Services. Based on Mode of Automation, the market is segmented into Fully-Automated Systems and Semi-Automated Systems. Based on End User, the market is segmented into Pharmaceutical Companies, Research Laboratories, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Based on Application, the market is segmented into Drug Discovery, Drug Development, Clinical Trials, Manufacturing, Packaging and Quality Control. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Automation Market

The Global Pharmaceutical Automation market is experiencing significant growth due to several key factors. Increasing integration of robotics in pharmaceutical manufacturing, government initiatives aimed at advancing industrial development, and heightened investments focused on upgrading conventional production facilities are driving this trend. Moreover, there is a surging consumer demand for safe and digitized production methods, which further fuels the adoption of automation technologies. This combination of technological advancement and changing market expectations is creating a robust environment for growth within the pharmaceutical automation sector, paving the way for innovative solutions and improved operational efficiencies in the industry.

Restraints in the Global Pharmaceutical Automation Market

The Global Pharmaceutical Automation market faces obstacles, yet it is projected that the significant demand for COVID-19 vaccine production, coupled with the increasing integration of Internet of Things (IoT) technologies in pharmaceutical manufacturing, will create considerable opportunities for industry growth. This trend highlights the dual impact of current healthcare needs and technological advancements, suggesting that while challenges exist, the potential for innovation and expansion in pharmaceutical automation is promising. As companies adapt to meet these demands, the landscape of the market is likely to evolve, offering prospects for improved efficiency and effectiveness in drug manufacturing processes.

Market Trends of the Global Pharmaceutical Automation Market

The global pharmaceutical automation market is experiencing significant growth, driven by an escalating demand for advanced technologies that minimize medication errors and enhance operational efficiency. Increasing regulatory pressure for safety and accuracy in drug production, coupled with a heightened focus on patient safety, is propelling investments in automation solutions. Additionally, the ongoing digital transformation, especially post-pandemic, has led to a surge in the adoption of artificial intelligence and robotics within pharmacies. This convergence of factors is fostering innovative solutions, streamlining workflows, and enabling better inventory management, ultimately contributing to the robust expansion of the pharmaceutical automation landscape worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Pharmaceutical Automation Market Size by Offering & CAGR (2025-2032)

• Market Overview
• Hardware
• Software
• Services

Global Pharmaceutical Automation Market Size by Mode of Automation & CAGR (2025-2032)

• Market Overview
• Fully-Automated Systems
• Semi-Automated Systems

Global Pharmaceutical Automation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Research Laboratories
• Contract Manufacturing Organizations (CMOs)
• Contract Research Organizations (CROs)

Global Pharmaceutical Automation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Drug Development
• Clinical Trials
• Manufacturing
• Packaging
• Quality Control

Global Pharmaceutical Automation Market Size & CAGR (2025-2032)

• North America (Offering, Mode of Automation, End User, Application)
  • US
  • Canada
• Europe (Offering, Mode of Automation, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Mode of Automation, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Mode of Automation, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Mode of Automation, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omnicell, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swisslog Healthcare (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capsa Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parata Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARxIUM (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScriptPro LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yuyama Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pearson Medical Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accu-Chart Plus Healthcare Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NewIcon (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AlixaRx (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KUKA AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TOSHO Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations